BIODESIX
Biodesix is a molecular diagnostics company advancing the development of innovative products for personalizing medicine. The company provides physicians with diagnostic tests for earlier disease detection, more accurate diagnosis, disease monitoring, and better therapeutic guidance, which may lead to improved patient outcomes. Biodesix discovers, develops, and commercializes multivariate protein diagnostics based on their proprietary mass spectrometry-based discovery platform. VeriStrat, a multi... variate serum protein test, is Biodesix’s first product developed with this technology. The commercially available test provides oncologists with information to help them select between erlotinib and single-agent chemotherapy for advanced lung cancer patients. Tests are processed in Biodesix’s CLIA-certified laboratory and results are reported in less than 72 hours. In addition to developing novel diagnostics independently, the company also partners with biotechnology and pharmaceutical companies to develop companion diagnostics to improve the utility of therapeutic agents.
BIODESIX
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2005-01-01
Address:
Broomfield, Colorado, United States
Country:
United States
Website Url:
http://www.biodesix.com
Total Employee:
101+
Status:
Active
Contact:
303-417-0500
Total Funding:
299.97 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving Global Site Tag
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Heinrich Röder CTO @ Biodesix
CTO
2000-01-01
Richard D. Hockett Chief Medical Office @ Biodesix
Chief Medical Office
Paul Beresford Chief Business Officer @ Biodesix
Chief Business Officer
2015-03-01
Doug Swan Vice President of Commercial Operations @ Biodesix
Vice President of Commercial Operations
2008-10-01
Kieran O'Kane Chief Commercial Officer @ Biodesix
Chief Commercial Officer
2020-03-01
Scott Hutton CEO @ Biodesix
CEO
Gary Pestano Chief Development Officer @ Biodesix
Chief Development Officer
Jim Purvis Vice President of Human Resources and Operational Effectiveness @ Biodesix
Vice President of Human Resources and Operational Effectiveness
2010-03-01
Robin Harper Cowie CFO @ Biodesix
CFO
2017-04-01
Steven Springmeyer CMO @ Biodesix
CMO
2018-07-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-06-28 | Oncimmune | Oncimmune acquired by Biodesix | N/A |
| 2018-07-09 | Integrated Diagnostics | Integrated Diagnostics acquired by Biodesix | N/A |
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Biodesix
CRG
CRG investment in Debt Financing - Biodesix
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-10 | Biodesix Announces New Commercial Organization and Executive Appointments |
Official Site Inspections
http://www.biodesix.com Semrush global rank: 2.75 M Semrush visits lastest month: 5.9 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biodesix"
Biodesix - Crunchbase Company Profile & Funding
Biodesix is a data-driven diagnostic solutions company that provides lung cancer diagnostic testing and biopharma services. The company provides physicians with diagnostic tests for earlier disease detection, more accurate diagnosis, …See details»
Our Purpose - Biodesix
Celebrating Team Biodesix! We are honored to be recognized with the following: 2024. Inc. Magazine – Best Workplaces 2024; Newsweek – World’s Best Digital Health Companies of 2024; Healthcare Technology Report – Scott Hutton, …See details»
Biodesix, Inc. - LinkedIn
Biodesix, Inc. | 16,209 followers on LinkedIn. Leader in Clinical Diagnostic Testing & Biopharma Services. ***INC. 2024 Best Workplaces*** | A leading diagnostic solutions company with five ...See details»
Our Leadership Team | Biodesix
Jean M. Franchi has served as a Director of the Company since April 2020.Ms. Franchi is currently Chief Financial Officer of Disc Medicine, Inc., a clinical stage company focused on …See details»
Newsroom Home - biodesix.com
Oct 30, 2018 See Biodesix-sponsored presentations and publications at upcoming industry events. View. Events. Connect with Team Biodesix at industry events and conferences. View. …See details»
Biodesix Announces New Commercial Organization …
Mar 10, 2020 The organization’s focus is to support the business development of early-stage… Learn More As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability reviews of the five prescription drugs …See details»
10-Q - SEC.gov
Mar 31, 2024 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements about us and our industry that involve substantial risks and uncertainties, including but not limited to those set forth under the caption “Special Note Regarding Forward-Looking Statements” and Item 1A.See details»
Biodesix Company Profile - Office Locations, Competitors ... - Craft
Biodesix has 5 employees across 2 locations and $49.09 m in annual revenue in FY 2023. See insights on Biodesix including office locations, competitors, revenue, financials, executives, …See details»
Biodesix Inc
Biodesix Inc. Biodesix Inc is a leading data-driven diagnostic solutions company with a primary focus on lung disease. They offer diagnostic tests and biopharma services to healthcare providers, researchers, and biopharmaceutical companies. Their purpose is to deliver personalized care by leveraging scientific expertise and providing timely and actionable …See details»
Biodesix Announces New Commercial Organization and Executive ...
Mar 10, 2020 Biodesix, Inc., a leading diagnostic company in lung cancer, today announced the realignment of their commercial executive team. Kieran O’Kane will be Biodesix Announces …See details»
Biodesix, Inc. (BDSX) Company Profile & Overview - Stock Analysis
Oct 28, 2020 Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify …See details»
Biodesix | Lab Manager
Nov 9, 2017 Organization profile for Biodesix on Lab Manager. GeneStrat is a genomic liquid biopsy test utilizing circulating tumor nucleic acids from plasma that is used by physicians to inform treatment of patients with non-small cell lung cancerSee details»
Investor Relations | Newsroom - Biodesix
Oct 29, 2024 Biodesix is a leading data-driven diagnostic solutions company leveraging state of the art technologies with our proprietary artificial intelligence platform to discover, develop, and …See details»
Biodesix Named a Top 100 Healthcare Technology Company of 2022
BOULDER, Colo.--(BUSINESS WIRE)--Aug. 9, 2022-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced it has …See details»
Physician Portal - Biodesix
Contact Client Services at 1.866.432.5930 to learn more about accessing the Biodesix Physician Portal.See details»
Biodesix Ranked Top Proteomics Solutions Company by Life …
Dec 12, 2022 BOULDER, Colo.--(BUSINESS WIRE)--Dec. 12, 2022-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, …See details»
Careers in Biotechnology | Boulder, CO - Biodesix
If you are an individual with a disability and require a reasonable accommodation to use our online system to search and/or apply for a position, please call us at (303) 892-3201 or send us an …See details»
Biodesix - Funding, Financials, Valuation & Investors - Crunchbase
Biodesix is registered under the ticker NASDAQ:BDSX . Their stock opened with $18.00 in its Oct 28, 2020 IPO. Biodesix is funded by 3 investors. Perceptive Advisors and Lincoln Park Capital Fund are the most recent investors. Biodesix has a post-money valuation in the range of $100M to $500M as of Feb 26, 2016, according to PrivCo. Sign up for ...See details»
Biodesix Named a Top 100 Healthcare Technology Company of 2022
Aug 9, 2022 Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced it has been recognized Biodesix Named a Top …See details»